Stage/Treatment | Mean Overall Survival, months ± SD | 1-Year Survival, % | 3-Year Survival, % | 5-Year Survival, % |
---|---|---|---|---|
Disease stagea | ||||
Very early (n=5) | 51.18 ± 14.70 | 100 | 100 | 50.0 |
Early (n=38) | 35.14 ± 24.0 | 84.2 | 47.4 | 20.7 |
Intermediate (n=14) | 27.76 ± 19.64 | 71.4 | 41.7 | 8.3 |
Advanced (n=6) | 5.79 ± 3.15 | 0 | 0 | 0 |
Treatment group | ||||
Surgery (n=32) | 35.42 ± 23.54 | 81.3 | 52.9 | 18.9 |
Surgery alone (n=19) | 26.68 ± 21.97 | 68.4 | 36.8 | 22.1 |
Surgery and locoregional (n=13) | 48.18 ± 20.26 | 100 | 76.9 | 17.1 |
Locoregional (n=31) | 28.42 ± 23.0 | 71.0 | 38.7 | 19.0 |
↵aDisease stage was determined by the Barcelona Clinic Liver Cancer staging classification system.